Physician

Corey D Clay, MD, PHD

According to 2025 Medicare claims, Corey Clay, MD, PHD (NPI: 1417247727) practices allergy/immunology in the Santa Fe, NM market, with the plurality of this provider's patient population coming from Santa Fe, NM. This provider's primary affiliated billing organization is ALLERGY PARTNERS, PLLC (NPI: 1225028541; TIN: 561249571) and primary practice location at 87505-4752. Clay is affiliated with the Healthcare Solutions Network (ACO ID: A3283) and CVS ACO (ACO ID: A5407), participating under the MSSP model.

Clay's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 506 traditional Medicare patients, billed 14,509 HCPCS/CPT codes, and received $253,512 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,490 prescription claims across 323 beneficiaries totaling $604,584 in drug costs, led by Xolair (Omalizumab). 2019 DME data shows 126 claims. Open Payments data shows 93 records totaling $2,071. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $17,060 to $253,512. Similarly, Part D prescription costs have risen steadily, from $31,417 to $604,584. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$127K$254K2016 Medicare payment: $17,060 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $54,212 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $43,014 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $61,514 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $126,332 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $186,812 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $174,348 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $237,084 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $253,512 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016132760$17,060
20172284,140$54,212
20182042,856$43,014
20194735,244$61,514
202051610,852$126,332
202151913,307$186,812
202253211,251$174,348
202356914,739$237,084
202450614,509$253,512

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$302K$605K2015 Drug cost: $31,417 (USD; Tot_Drug_Cst)2016 Drug cost: $12,745 (USD; Tot_Drug_Cst)2017 Drug cost: $67,646 (USD; Tot_Drug_Cst)2018 Drug cost: $161,857 (USD; Tot_Drug_Cst)2019 Drug cost: $181,742 (USD; Tot_Drug_Cst)2020 Drug cost: $78,886 (USD; Tot_Drug_Cst)2021 Drug cost: $196,357 (USD; Tot_Drug_Cst)2022 Drug cost: $255,018 (USD; Tot_Drug_Cst)2023 Drug cost: $513,287 (USD; Tot_Drug_Cst)2024 Drug cost: $604,584 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20151664$31,417
201669241$12,745
2017144712$67,646
20181921,065$161,857
2019183873$181,742
2020173665$78,886
2021192934$196,357
2022221941$255,018
20232771,463$513,287
20243231,490$604,584

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$63K$127K2018 Medicare payment: $126,924 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $86,409 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/R108$126,924
2019N/R126$86,409
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
2023N/RN/RN/R
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more152215$85
95165Professional service for preparation and provision of 1 or more antigens1192,125$9
95117Professional service for multiple injections of allergen1981,495$7
95115Professional service for single injection of allergen87884$6
96160Administration and interpretation of patient-focused health risk assessment205270$2

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
XolairOmalizumab581,624$165,831
Dupixent SyringeDupilumab23644$81,851
Dupixent PenDupilumab18504$66,007
Gammagard LiquidImmun Glob G(Igg)/Gly/Iga Ov5024672$50,090
Gamunex-CImmune Globul G/Gly/Iga Avg 4623644$49,337

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.93$2,071AstraZeneca Pharmaceuticals LP
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Corey D. Clay, MD, PHD?

Tedicare shows public-source Medicare data for Corey D. Clay, MD, PHD (NPI 1417247727), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Corey D. Clay, MD, PHD have ACO affiliation data?

Corey D. Clay, MD, PHD is shown with ACO affiliation data for Healthcare Solutions Network (MSSP, ACO ID A3283) and CVS ACO (MSSP, ACO ID A5407).

What billing organization is linked to Corey D. Clay, MD, PHD?

Corey D. Clay, MD, PHD is linked to ALLERGY PARTNERS, PLLC (billing NPI 1225028541) in the available physician profile data.

Does Corey D. Clay, MD, PHD have Open Payments data?

Corey D. Clay, MD, PHD has 93 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.